"AIRPORT MALARIA":
EXPERTS WARN OF A DEADLY RISK
READY TO LAND IN MANY COUNTRIES
Health authorities in many countries are becoming increasingly
concerned about the potentially deadly risks of malaria carried into their territory by
"jet-setting" mosquitoes that travel on international flights and spread the
disease, according to a study published in the August issue of The Bulletin of the
World Health Organization.
Between 1969 and 1999, 12 countries reported a total of 87 cases of
malaria in people living near an airport. France heads the list, with 26 cases, followed
by Belgium, 16, and the United Kingdom, 14 cases. These "airport malaria" cases,
occurring in or near airports, are distinguished from other cases of imported malaria
among persons who contract the infection during a stay in a malarious area and
subsequently fall ill. The occurrence of a relatively large number of cases of airport
malaria in Paris and Brussels reflects the large number of flights arriving from Central
and West Africa. At least five deaths have resulted; all cases occurred among people with
no immunity to the disease. Long delays in achieving the correct diagnosis frequently
resulted in-patients developing severe or complicated malaria. Five cases of airport
malaria occurred in Switzerland in 1990; in at least one case, 31 days elapsed before a
correct diagnosis was made
"A serious consequence of the transport of infected mosquitoes
aboard aircraft has been the numerous cases of "airport malaria" reported from
Europe, North America and elsewhere," say the authors of the report. Airport malaria
is particularly dangerous in that physicians generally have little reason to suspect it.
This is especially true if there has been no recent travel to areas where malaria is
endemic. Diagnosis may, therefore, be protracted and death may occur before a correct
diagnosis is made and adequate treatment provided."
In some instances, mosquito species have been established in countries
in which they have not previously been reported. The study quotes the introduction
probably by ship rather than aircraft - into Brazil in 1930 of a species of mosquito that
was a major vector of malaria. "The importation and subsequent establishment of this
highly efficient vector led to an epidemic of malaria involving some 300 000 cases and 16
000 deaths. A costly campaign was successfully conducted to eradicate the vector from
Brazil."
The authors of the Bulletin study are Dr Norman Gratz, former
Director of the Division of Vector Biology and Control, WHO, Dr Robert Steffen, of the
University Travel Clinic, Institute for Social and Preventive Medicine, Zurich University,
and Dr William Cocksedge, a communicable diseases specialist at WHO. "There is an
important on-going need for the disinsection of aircraft coming from airports in tropical
disease endemic areas into non-endemic areas," they say.
"Malaria-carrying mosquitoes may enter the passenger cabin before
take-off or during stopovers or may survive the trip in the luggage hold. Whatever its
mode of travel, imported malaria is frequently fatal, due to late diagnosis by physicians
not primed to the risk of malaria. The cost of treating it can exceed US$ 2700 per case,
which far outweighs the cost of disinsection of aircraft with periodic application of a
residual insecticide, such as permethrin, plus aerosol spraying either just before
passengers board or just before take-off."
Many countries already insist that arriving aircraft be disinsected,
especially if they have come from areas where vector-borne diseases are endemic. It is
common for an arriving aircraft to be sprayed by the health services of the country of
destination if there is any doubt as to whether treatment has been applied earlier in the
flight. The latest WHO recommendations for aircraft disinsection were published in 1998.
- The first reported occurrence of insects in an aircraft was in 1928 when a quarantine
inspector boarded the dirigible Graf Zeppelin on its arrival in the USA: 10 species
of insects were discovered on plants carried by passengers.
Also in this month's Bulletin
Prevention of neonatal HIV: questions galore
Preventing mother-to-child transmission of HIV in developing
countries might soon be technically feasible, judging from the results of recent trials of
zidovudine and nevirapine in Thailand and Uganda. These results raise hopes but also many
questions. Given the cost of such drugs, would developing countries not be better advised
to put their money into the distribution of condoms and health education to prevent HIV
infection in adults, particularly pregnant women? Should bolstering basic health services
and thereby reducing child mortality not be a top priority for resources? Would the
availability of such treatment not increase the prevalence of high-risk behaviour and the
number of HIV-infected children? The overriding consideration should be to safeguard the
rights of women to adequate health care and social support, including proper counselling.
Measuring health measures
Over the last four decades, health analysts have been devising
indices or measures of health that aim to summarize a population's health. A valuable
health measure is one that can be used, among other things, to compare the levels of
health enjoyed by different populations, to monitor changes in a population's health,
to quantify health inequalities within a population and to assess the impact of non-fatal
health problems on a population's overall health. None of the measures currently
available fulfils all the criteria but decision-makers should not wait before using those
that come closest to the ideal.
Cervical lesions magnified
In India cervical cancer is the leading malignancy in women, with
about 90 000 new cases reported annually. In more than 90% of these cases, the
lesions are in an advanced stage by the time the patient seeks medical care. In
industrialized countries, mass cytological screening has largely brought the problem under
control, at a cost prohibitive for most developing countries. A study using a new type of
elongated magnifying glass that illuminates and magnifies the cervix - the
"magnivisualizer - detected 77% of cases of confirmed early cervical cancer. The
method, which is inexpensive and practicable in a primary health care setting, offers a
valid method of screening for cervical cancer in countries that cannot afford cytological
screening.
________________________________________________________________________
For further information please contact Mr William Cocksedge, Regulatory Health
Specialist, WHO, Geneva. Tel. (+41 22) 791 2729. Email: cocksedgew@who.int
or Mr Thomson Prentice, WHO, Geneva. Tel. (+41 22) 791 4224. Email: prenticet@who.int. All WHO Press Releases, Fact Sheets
and Features can be obtained on Internet on the WHO home page http://www.who.int The Bulletin is available on the web at www.who.int/bulletin |